Metformin Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Sandoz, is a biguanide presented as an oral dosage form for oral use. It treats type 2 diabetes mellitus in adults.

GNH USA supplies Metformin Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Sandoz is a biguanide indicated for the management of type 2 diabetes mellitus, helping to achieve better glycaemic control.

- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels and improves overall glycaemic control.

Metformin Sandoz may cause a range of adverse reactions. Patients should be aware of both frequent and rare events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: severe metabolic acidosis, potentially life‑threatening. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia (when combined with insulin or sulfonylureas). - Vitamin B12 deficiency: may cause neuropathy with long‑term use. - Acute pancreatitis: rare inflammation of the pancreas.

Metformin Sandoz requires careful consideration of patient‑specific factors before initiation.

- Renal function: assess creatinine clearance; avoid if severe impairment. - Hepatic function: use with caution in liver disease. - Lactic acidosis risk: discontinue before radiographic contrast studies. - Vitamin B12 monitoring: periodic assessment recommended for long‑term therapy. - Pregnancy and breastfeeding: evaluate risk‑benefit; use only if clearly needed. - Storage: Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Metformin Sandoz can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - MAO inhibitors: risk of severe hypotension.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., thiazides): may affect renal clearance. - Corticosteroids: can raise blood glucose, requiring dose adjustment. - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Alcohol: excessive intake increases lactic acidosis risk.